
22 Dec '25
24 Dec '25
₹108 - ₹114
₹14,592
128
NSE
1,32,26,880
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) specializes in providing multispeciality healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India. The company operates seven multispeciality hospitals and four pharmacies with a total bed capacity of 490 beds, an approved capacity of 455 beds, and an operat
| Investory Category | Subscription Percentage | Amount Raised (₹ Crores) |
|---|---|---|
| Qualified Institutional Buyers (QIBs) | 75% | 99,20,160 crores |
| Non-Institutional Investors (NIIs) | 15% | 19,84,032 crores |
| Retail Individual Investors (RIIs) | 10% | 13,22,688 crores |
| Allotment Date | Listing Date | Refund Date |
|---|---|---|
| 26 Dec '25 | 30 Dec '25 | 29 Dec '25 |
| Issue Composition: | |
|---|---|
| Face Value | ₹0 per share |
| Total Issue Size | 1,32,26,880 shares (aggregating up to ₹14,592 crores) |
| Fresh Issue | NaN shares (aggregating up to To be announced) |
| Offer for Sale | NaN shares of ₹0 (aggregating up to To be announced) |
| Issue Type | |
| Post-Issue Shareholding Pattern: | |
|---|---|
| Pre-Issue Shareholding | shares |
| Post-Issue Shareholding | 0 shares |
| Minimum Lot Size | -- |
| Maximum Lot Size (Retail) | -- |
The lot size of Gujarat Kidney and Super Speciality ipo has been designed to ensure broad participation while maintaining optimal price discovery.
| Book Running Lead Manager(s) |
|---|